- 2015 American Transplant Congress - A Novel Maintenance Regimen With Calcineurin Inhibitor, MMF and Everolimus Initiated By Dual Induction Therapy With Anti-CD20/25 Antibodies in Renal Transplantation- Surgery III, Tokyo Women's Medical University Hospital, Shinjuku-ku,Tokyo, Japan. 【background】Calcineurin inhibitor (CNI), MMF and steroid has been the gold standard of maintenance regimen in renal transplantation (RTx). A line of new immunosuppressants has emerged…
- 2015 American Transplant Congress - Longitudinal Assessment of Endothelial Function Following Kidney TransplantationPurpose:Evaluate the progression of endothelial function as a marker of cardiovascular disease following kidney transplant.Background:Endothelial dysfunction is associated with cardiovascular disease (CVD) in end stage…
- 2015 American Transplant Congress - Active Immunization in Patients Transplanted for Hepatitis B Virus Related Liver Diseases: A Preliminary Report of a Prospective StudyAims: The aim of this study was to prospectively investigate the effectiveness and safety of procedural HBV vaccine in patients transplanted for hepatitis B virus…
- 2015 American Transplant Congress - Renal Function Following Basiliximab Induction in Liver Transplant Recipients- Washington University School of Medicine, St. Louis. Purpose: Reports of the use of antibody induction to delay the start of calcineurin inhibitor therapy postoperatively in patients with renal insufficiency at the time…
- 2015 American Transplant Congress - Incidence and Risk Factors for Infectious Complications in Liver Transplant Patients Converted to EverolimusAIM:Immunosuppression with an mTOR inhibitor plus calcineurin inhibitor (CNI) minimization is increasingly used in liver transplantation to protect against the nephrotoxic and neurotoxic side effects…
- 2015 American Transplant Congress - Financial Impact of an Advanced Liver Disease Service on a Tertiary Health SystemRegional disparities in liver transplantation motivated revision of national organ-sharing policies towards critically ill patients. Liver transplantation of high MELD patients incorporates significant institutional commitment…
- 2015 American Transplant Congress - Human CD8+TCR– Facilitating Cells Enhance HSC Engraftment In Vivo and Promote HSC Survival In VitroCD8+/TCR- facilitating cells (FC) in mouse BM significantly enhance engraftment of hematopoietic stem cells (HSC) in syngeneic and allogeneic recipients. Human FC phenotype and mechanism…
- 2015 American Transplant Congress - Targeted Rapamycin Nanotherapy Dampens Memory T Cell FunctionMemory T cells (Tm) are difficult to control post-transplantation and account for early rejection episodes. Additionally, therapies exerting local immunosuppression by targeting an allograft, while…
- 2015 American Transplant Congress - Prevalence and Clinical Outcomes Associated With Vancomycin-Resistant Enterococcal Colonization Or Infection After Small Intestinal TransplantationBACKGROUND: Vancomycin-resistant enterococcal (VRE) infections cause significant morbidity and mortality amongst SOT recipients. However, little is known about the relevance of VRE in small intestinal…
- 2015 American Transplant Congress - Evaluating the Benefits of Everolimus on Cardiac Allograft Vasculopathy: Further Evidence from Results of Imputations for Missing IVUS Data from A2310 StudyPurpose: A2310 IVUS study showed that everolimus (EVR) provides cardiac allograft vasculopathy (CAV) benefit compared to mycophenolate mofetil (MMF) by assessing the mean change in…
- « Previous Page
- 1
- …
- 128
- 129
- 130
- 131
- 132
- …
- 170
- Next Page »
